↓ Skip to main content

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

Overview of attention for article published in Breast Cancer Research, January 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
3 X users
patent
2 patents

Citations

dimensions_citation
260 Dimensions

Readers on

mendeley
214 Mendeley
Title
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Published in
Breast Cancer Research, January 2012
DOI 10.1186/bcr3099
Pubmed ID
Authors

Sabine Kasimir-Bauer, Oliver Hoffmann, Diethelm Wallwiener, Rainer Kimmig, Tanja Fehm

Abstract

The presence of circulating tumor cells (CTC) in breast cancer might be associated with stem cell-like tumor cells which have been suggested to be the active source of metastatic spread in primary tumors. Furthermore, to be able to disseminate and metastasize, CTC must be able to perform epithelial-mesenchymal transition (EMT). We studied the expression of three EMT markers and the stem cell marker ALDH1 in CTC from 502 primary breast cancer patients. Data were correlated with the presence of disseminated tumor cells (DTC) in the bone marrow (BM) and with clinicopathological data of the patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 214 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 2%
Portugal 2 <1%
Spain 2 <1%
India 1 <1%
Germany 1 <1%
Italy 1 <1%
China 1 <1%
Unknown 201 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 49 23%
Student > Ph. D. Student 47 22%
Student > Master 22 10%
Student > Bachelor 16 7%
Student > Doctoral Student 14 7%
Other 35 16%
Unknown 31 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 54 25%
Medicine and Dentistry 51 24%
Biochemistry, Genetics and Molecular Biology 42 20%
Engineering 19 9%
Chemistry 3 1%
Other 7 3%
Unknown 38 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2022.
All research outputs
#7,204,882
of 25,373,627 outputs
Outputs from Breast Cancer Research
#824
of 2,052 outputs
Outputs of similar age
#59,942
of 251,776 outputs
Outputs of similar age from Breast Cancer Research
#12
of 40 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,776 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.